Serum amyloid P component levels are not decreased in patients with systemic lupus erythematosus and do not rise during an acute phase reaction

समान संसाधन

• Mycophenolate mofetil prevents a clinical relapse in patients with systemic lupus erythematosus at risk
  द्वारा: Bijl, M, और अन्य
  प्रकाशित: (2003)
• Reduced uptake of apoptotic cells by macrophages in systemic lupus erythematosus: correlates with decreased serum levels of complement
  द्वारा: Bijl, M, और अन्य
  प्रकाशित: (2006)
• Serum amyloid P component (SAP) binds to late apoptotic cells and mediates their phagocytosis by macrophages
  द्वारा: Bijl, M, और अन्य
  प्रकाशित: (2002)
• Expression of costimulatory molecules on peripheral blood lymphocytes of patients with systemic lupus erythematosus
  द्वारा: Bijl, M, और अन्य
  प्रकाशित: (2001)
• Anti-serum amyloid component P antibodies in patients with systemic lupus erythematosus correlate with disease activity
  द्वारा: Zandman-Goddard, G, और अन्य
  प्रकाशित: (2005)